ARCON.
作者信息
Rojas A
机构信息
Gray Laboratory CRT, Mount Vernon Hospital, Northwood, Middlesex.
出版信息
Strahlenther Onkol. 1996 Nov;172 Suppl 2:34-5.
PMID:8946047
Abstract
摘要
相似文献
1
ARCON.电弧控制法
Strahlenther Onkol. 1996 Nov;172 Suppl 2:34-5.
2
The potential for improving radiotherapy outcome by improving the oxygen supply to solid tumours.
Strahlenther Onkol. 1996 Nov;172 Suppl 2:22-3.
3
ARCON.加速康复与认知导向手术（ARCON）
Clin Oncol (R Coll Radiol). 1994;6(5):281-2. doi: 10.1016/s0936-6555(05)80266-3.
4
5
Is hyperbaric oxygen more effective than carbogen/nicotinamide in tumor radiation response?
Radiat Res. 1997 Nov;148(5):523-5.
6
Oxygen-modifying treatment with ARCON reduces the prognostic significance of hemoglobin in squamous cell carcinoma of the head and neck.采用ARCON进行的氧修饰治疗降低了血红蛋白在头颈部鳞状细胞癌中的预后意义。
Int J Radiat Oncol Biol Phys. 2006 Jan 1;64(1):83-9. doi: 10.1016/j.ijrobp.2005.07.003. Epub 2005 Oct 5.
7
Carbogen and nicotinamide: expectations too high?卡波金和烟酰胺：期望过高？
Radiother Oncol. 1992 Jun;24(2):75-6. doi: 10.1016/0167-8140(92)90281-x.
8
Early skin response to fractionated doses of pions for determining therapeutic gain factors.早期皮肤对分次剂量π介子的反应以确定治疗增益因子。
Tokai J Exp Clin Med. 1996 Jun;21(2):69-75.
9
Preclinical studies on how to deal with patient intolerance to nicotinamide and carbogen.关于如何应对患者对烟酰胺和混合气体不耐受的临床前研究。
Radiother Oncol. 2004 Mar;70(3):301-9. doi: 10.1016/j.radonc.2004.01.017.
10
Extrapolations from laboratory and preclinical studies for the use of carbogen and nicotinamide in radiotherapy.关于放疗中使用卡波金和烟酰胺的实验室及临床前研究的推断。
Radiother Oncol. 1992 Jun;24(2):123-4. doi: 10.1016/0167-8140(92)90292-3.
Zotero 插件